Clinical trialNCT06805305RecruitingPhase 2Interventional

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

SponsorDiakonos Oncology CorporationEnrollment180Glioblastoma (GBM)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
Active, not recruiting
City of Hope
Duarte, California, United States
Jana Portnow, MD
Recruiting
Hoag
Newport Beach, California, United States
Simon Khagi, MD
Recruiting
Ucsf
San Francisco, California, United States
Thomas Nelson, MD
Recruiting
Baptist Md Anderson Cancer Center
Jacksonville, Florida, United States
Robert Cavaliere, MD
Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting
Cooper University Health Care
Camden, New Jersey, United States
Alan Turtz, MD
Recruiting
Rutgers Cancer Institute
New Brunswick, New Jersey, United States
Morana Vojnic, MD
Recruiting
Atlantic Health
Summit, New Jersey, United States
Robert Aiken, MD
Recruiting
Lenox Hill Hospital
New York, New York, United States
Recruiting
Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Dominique Higgins, MD
Recruiting
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Roy E Strowd III, MD
Recruiting
the Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
J. Bradley Elder, MD
Recruiting
Upmc Presbyterian Hospital
Pittsburgh, Pennsylvania, United States
Costas Hadjipanayis, MS, MD, PhD
Recruiting
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Ryan Merrell, MD
Recruiting
Baylor College of Medicine
Houston, Texas, United States
Jacob Mandel, MD
Recruiting
Uthealth Houston
Houston, Texas, United States
Nitin Tandon, MD
Recruiting
the University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Andrew Brenner, MD, PhD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 Mar 2025
Primary completion: 31 Mar 2030
Completion: 31 Mar 2032
Last update posted: 1 Jul 2026
Registered enrollment: 180
Registry id: NCT06805305

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.